Dr. Fakouri Baygi is the Founder and Chief Executive Officer of Linker Sciences. He has over 10 years of experience in both computational and experimental mass spectrometry, with a focus on applying high-resolution instrumentation to drug discovery and molecular characterization. His work spans method development, large-scale data analysis, cheminformatics, and the design of precision workflows for characterizing unknown compounds in complex matrices.

Sadjad has led projects across academia and industry, building analytical platforms that integrate mass spectrometry with AI and automation. His expertise includes instrument physics, experimental design, and the development of scalable data pipelines for compound discovery and characterization. At Linker Sciences, he is building a disruptive, mass spectrometry-powered platform aimed at redefining how small molecule drugs are discovered and validated.